Skip to content
Dose Brief
Menu

TeleDocs360 Review — GLP-1 Enrollment Unconfirmed

By Updated

TeleDocs360 lists monthly GLP-1 prices, but its public navigation sends both medication choices to a waitlist.

Historical Brief Score63/100Recorded grade CDirectory position by recorded score: 319
View published plan information View current availability and member information.
Semaglutide

$229/month on the advertised standard plan. Confirm enrollment.

Tirzepatide

$349/month on the advertised standard plan. Confirm enrollment.

Current availability
Confirm access for your state and selected plan.
Prescription offer
Current prescription offer unconfirmed
AvailabilityPrescription availability unconfirmed— Published prices are visible. Confirm whether the plan is accepting new patients.

TeleDocs360 in depth

Published prices and the waitlist

The weight-loss page (opens in a new tab) lists standard semaglutide at $229 monthly and standard tirzepatide at $349 monthly. The billing guide can help compare those rates with the separately listed lower-dose plans and three-month options. The main Get Started link and medication navigation point to a waitlist. Individual price cards link to separate plan routes, so the published prices alone do not establish whether new patients can enroll.

What the plan covers

The weight-loss page says the plan price includes provider review, medication if prescribed, and shipping. Use the pharmacy checklist to confirm who would dispense the prescription and which preparation is quoted. Compounded medications are not FDA-approved.

Renewal and pharmacy cutoff

The terms (opens in a new tab) specify 30-day and 90-day renewals and describe refunds for orders canceled before they are sent to the pharmacy. Use the cancellation checklist to check the notice period and whether a particular shipment can still be stopped.

Sources we checked

Public program pages and terms, checked November 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

Historical score

Retained from the earlier program listing; this score does not rate current prescription availability. See the methodology.

Price Stability46/100
Supply Reliability69/100
Transparency72/100
Access Breadth56/100
Clinical Oversight77/100
Track Record68/100

What the sources establish

  • Separates standard and lower-dose pricing
  • Publishes prescription refund and renewal terms

What still needs checking

  • The medication navigation points to a waitlist
  • A posted rate does not establish an enrollment date

The brief

Useful for: Readers comparing published plans who can confirm when enrollment opens. TeleDocs360 lists monthly GLP-1 prices, but its public navigation sends both medication choices to a waitlist.

The score above is a historical assessment of the earlier listing, not a recommendation for current treatment. Compare current provider information before choosing care.

Before you decide

The questions readers ask next after reading about TeleDocs360.

Closest here

Directory neighbors by retained score; a status assessment does not establish current prescription availability.

Weighing TeleDocs360 against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs TeleDocs360, and every provider that outranks it is listed on the TeleDocs360 alternatives ranking.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect TeleDocs360's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on TeleDocs360's site. Not medical advice; see our disclosure.

← Back to all rankings